Drug – bio-affecting and body treating compositions – Antigen – epitope – or other immunospecific immunoeffector – Virus or component thereof
Patent
1994-10-13
1998-02-03
Smith, Lynette F.
Drug, bio-affecting and body treating compositions
Antigen, epitope, or other immunospecific immunoeffector
Virus or component thereof
4242041, 4351721, 4351723, 435236, A61K 39245, A61K 3912, C12N 1500, C12N 704
Patent
active
057141525
ABSTRACT:
Compositions which are useful for treatment of individuals for Herpes Simplex Virus (HSV) infections are provided, as are methods for their use. These compositions are comprised of immunogenic polypeptides which are comprised of an epitope of HSV VP16; they may also be comprised of an epitope of an HSV glycoprotein. Also provided are polypeptides which are used in the compositions for treating individuals for HSV infection, and methods and compositions used in the production of the polypeptides.
REFERENCES:
patent: 4618578 (1986-10-01), Burke et al.
patent: 4642333 (1987-02-01), Person
patent: 4661349 (1987-04-01), Kino et al.
patent: 4818694 (1989-04-01), Watson et al.
patent: 4855224 (1989-08-01), Berman et al.
patent: 4859587 (1989-08-01), Roizman
patent: 4891315 (1990-01-01), Watson et al.
Mackett, et al, 1984, "General Method for Production and . . . " J. Virol. 49(3):857-864.
Moss, J. gen Virol. (1989) 70:1579-1585.
Capone and Werstuck, Mol. Cell Biochem. (1990) 94(1):45-52.
Cress and Triezenberg, Gene (1991) 103:235-238.
Dowbenko et al., "Extensive Homology Between the Herpes Simplex Virus Type 2 Glycoprotein F Gene and the Herpes Simplex Virus Type 1 Glycoprotein C Gene" J. Virol. (1984) 52(1):154-163.
Draper et al., "Molecular Basis of the Glycoprotein-C-Negative Phenotype of Herpes Simplex Virus Type 1 Macrophage Strain" J. Virol. (1984) 51(3):578-585.
Frink et al., "Detailed Analysis of the Portion of the Herpes Simplex Virus Type 1 Genome Encoding Glycoprotein C" J. Virol. (1983) 45(2):634-647.
Homa et al., "Molecular Basis of the Glycoprotein C-Negative Phenotypes of Herpes Simplex Virus Type 1 Mutants Selected with a Virus-Neutralizing Monoclonal Antibody" J. Virol. (1986) 58(2):281-289.
Lasky et al., "DNA Sequence Analysis of the Type-Common Glycoprotein-D Genes of Herpes Simplex Virus Types 1 and 2" DNA (1984) 3(1):23-29.
McGeoch et al., "Sequence Determination and Genetic Content of the Short Unique Region in the Genome of Herpes Simplex Virus Type 1" J. Mol. Biol. (1985) 181:1-13.
Muggeridge et al., "Herpes simplex virus" in Immunochemistry of viruses, II. The basis for serodiagnosis and vaccines, Eds. van Regenmortel et al. (1990) Elsevier Science Publishers, 460-481.
Pellett et al., "Anatomy of the Herpes Simplex Virus 1 Strain F Glycoprotein B Gene: Primary Sequence and Predicted Protein Structure of the Wild Type and of Monoclonal Antibody-Resistant Mutants" J. Virol. (1985) 53(1):243-253.
Roger J. Watson, "DNA sequence of the Herpes simplex virus type 2 glycoprotein D gene" Gene (1983) 26:307-312.
David M. Koelle et al., "Antigenic Specificities of Human CD4.sup.+ T-Cell Clones Recovered from Recurrent Genital Herpes Simplex Virus Type 2 Lesions," J. of Virol. (1994) 68(5):2803-2810.
Campbell et al., J. Mol. Biol. (1984) 180:1-19.
Eberle et al., J. gen. Virol. (1984) 65:1839-1843.
McGeoch et al., J. gen Virol. (1988) 69:1531-1574.
McLean et al., J. gen. Virol. (1982) 63:297-305.
Spear et al., J. Virol. (1972) 9(1):143-159.
Triezenberg et al., Genes and Development (1988) 2:718-729.
Pellett et al., Proc. Natl. Acad. Sci. (1985) 82:5870-5874.
Sadowski et al., Nature (1988) 335:563-564.
Stringer et al., Nature (1990) 345:783-786.
Bzik et al., Virology (1984) 133:301-314.
Pachl et al., J. Virol. (1987) 61(2):315-325.
Stuve et al., J. Virol. (1987) 61(2):326-335.
Berman et al., Science (1985) 227:1490-1492.
Berman et al., Science (1983) 222:524-527.
Cohen et al., J. Virol. (1984) 49(1):102-108.
Lasky et al., Bio/Technology (Jun. 1984) pp. 527-532.
Watson et al., Science (1982) 218:381-384.
Weiss et al., Nature (1983) 302:72-74.
Stanberry et al., J. Infect. Dis. (1987) 155(5):914-920.
Burke Rae Lyn
Sekulovich Rose E.
Blackburn Robert P.
Chiron Corporation
McClung Barbara G.
Robins Roberta L.
Smith Lynette F.
LandOfFree
Herpes simplex virus VP16 vaccines does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Herpes simplex virus VP16 vaccines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Herpes simplex virus VP16 vaccines will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-659989